Yoshimasa Nakamura Selected Research

Yoshimasa Nakamura Research Topics

Disease

16	Neoplasms (Cancer) 11/2022 - 01/2000
11	Inflammation (Inflammations) 01/2016 - 01/2002
6	Carcinogenesis 07/2008 - 01/2000
5	Hepatocellular Carcinoma (Hepatoma) 10/2018 - 01/2002
4	T-Cell Leukemia (Leukemia, T Cell) 06/2018 - 09/2003
4	Colonic Neoplasms (Colon Cancer) 11/2017 - 07/2004
3	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 01/2017
3	Leukemia 01/2012 - 11/2008
3	Edema (Dropsy) 07/2004 - 06/2002
2	Phototoxic Dermatitis (Phototoxicity) 07/2022 - 05/2009
2	Chronic Disease (Chronic Diseases) 02/2022 - 04/2018
2	Acute Promyelocytic Leukemia 04/2014 - 05/2002
2	Ischemia 10/2011 - 07/2008
2	Necrosis 10/2008 - 03/2002
2	Skin Neoplasms (Skin Cancer) 08/2004 - 03/2003
1	Breast Neoplasms (Breast Cancer) 09/2022
1	Erythema 07/2022
1	Colitis 07/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2021
1	Obesity 01/2018
1	Hypertrophy 01/2017
1	Disease Progression 01/2016
1	Stomach Neoplasms (Stomach Cancer) 05/2011
1	Neuroblastoma 01/2009

Drug/Important Bio-Agent (IBA)

11	benzyl isothiocyanateIBA 11/2022 - 03/2002
5	AntioxidantsIBA 07/2011 - 01/2002
5	Proteins (Proteins, Gene)FDA Link 05/2011 - 05/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 12/2004
3	Glutathione (Reduced Glutathione)IBA 07/2021 - 10/2012
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2018 - 06/2002
3	hypobromous acidIBA 01/2016 - 12/2004
3	Peroxidase (Myeloperoxidase)IBA 01/2016 - 07/2008
3	Hypochlorous Acid (Hypochlorite)IBA 01/2016 - 07/2008
3	Eosine I BluishIBA 10/2014 - 06/2012
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2009 - 01/2000
3	Caspase 3 (Caspase-3)IBA 11/2008 - 03/2002
3	Superoxides (Superoxide)IBA 07/2008 - 05/2002
3	zerumboneIBA 08/2004 - 05/2002
3	SesquiterpenesIBA 08/2004 - 05/2002
2	AcetaldehydeIBA 02/2022 - 10/2017
2	EnzymesIBA 10/2018 - 07/2004
2	CytokinesIBA 06/2018 - 01/2015
2	Interleukin-13IBA 06/2018 - 01/2015
2	Aldehyde DehydrogenaseIBA 10/2017 - 10/2017
2	momfluorothrinIBA 01/2017 - 01/2017
2	Constitutive Androstane ReceptorIBA 01/2017 - 01/2017
2	Pyrethrins (Pyrethroids)FDA Link 01/2017 - 01/2017
2	Amino Acids FDA Link 01/2016 - 05/2007
2	AcidsIBA 11/2015 - 12/2004
2	PolyphenolsIBA 01/2014 - 05/2011
2	TeaIBA 05/2011 - 07/2008
2	IsothiocyanatesIBA 01/2009 - 01/2004
2	CaspasesIBA 10/2008 - 03/2002
2	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2008 - 05/2002
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2003 - 01/2002
2	PhytochemicalsIBA 05/2002 - 01/2000
1	Interleukin-4 (Interleukin 4)IBA 09/2022
1	Interleukin-10 (Interleukin 10)IBA 09/2022
1	Rutin (Rutoside)IBA 07/2022
1	TabletsIBA 07/2022
1	QuercetinIBA 02/2022
1	Food IngredientsIBA 02/2022
1	GlycosidesIBA 02/2022
1	LuteolinIBA 07/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 07/2021
1	Drinking WaterIBA 07/2021
1	Serotonin (5 Hydroxytryptamine)IBA 07/2021
1	Dextrans (Dextran)FDA Link 07/2021
1	Multidrug Resistance-Associated ProteinsIBA 07/2021
1	Therapeutic UsesIBA 11/2020
1	fucoxanthinIBA 11/2020
1	CyclodextrinsIBA 12/2018
1	CholesterolIBA 12/2018
1	InterleukinsIBA 06/2018
1	Glutathione Transferase (Glutathione S-Transferase)IBA 06/2018
1	FlavonoidsIBA 04/2018
1	LeptinIBA 01/2018
1	phenethyl isothiocyanate (PEITC)IBA 01/2018
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2018
1	3,4-Dihydroxyphenylacetic AcidIBA 10/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	(2,3,5,6- tetrafluoro- 4- methoxymethylphenyl)methyl- 2,2- dimethyl- 3- (1- propenyl)cyclopropanecarboxylateIBA 01/2017
1	ErgothioneineIBA 01/2016
1	AllergensIBA 01/2015
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2014
1	Sulfhydryl Compounds (Thiols)IBA 01/2014
1	Cysteine (L-Cysteine)FDA Link 10/2012
1	Macrophage Migration-Inhibitory FactorsIBA 10/2012
1	isothiocyanic acidIBA 10/2012
1	Proline (L-Proline)FDA Link 10/2012
1	Food Coloring AgentsIBA 06/2012
1	Tocopherols (Tocopherol)IBA 01/2012
1	hydroxide ionIBA 10/2011
1	DEAD-box RNA HelicasesIBA 05/2011
1	Docosahexaenoic AcidsIBA 01/2009

Therapy/Procedure

2	Therapeutics 05/2009 - 07/2008
2	Chemoprevention 05/2002 - 01/2000
1	Oral Administration 07/2022
1	Withholding Treatment 01/2017
1	Photochemotherapy (Photodynamic Therapy) 04/2014